1. Home
  2. SGHT vs ELME Comparison

SGHT vs ELME Comparison

Compare SGHT & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$4.00

Market Cap

187.4M

Sector

Health Care

ML Signal

HOLD

Logo Elme Communities

ELME

Elme Communities

HOLD

Current Price

$2.04

Market Cap

198.2M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
ELME
Founded
2011
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
187.4M
198.2M
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
SGHT
ELME
Price
$4.00
$2.04
Analyst Decision
Buy
Hold
Analyst Count
7
3
Target Price
$9.08
$12.67
AVG Volume (30 Days)
373.6K
1.2M
Earning Date
03-04-2026
04-30-2026
Dividend Yield
N/A
752.97%
EPS Growth
28.16
N/A
EPS
N/A
N/A
Revenue
$77,363,000.00
$206,360,000.00
Revenue This Year
$11.81
$5.03
Revenue Next Year
$10.62
$4.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$1.98
52 Week High
$9.24
$17.68

Technical Indicators

Market Signals
Indicator
SGHT
ELME
Relative Strength Index (RSI) 42.49 18.07
Support Level $3.99 N/A
Resistance Level $4.33 $2.26
Average True Range (ATR) 0.22 0.04
MACD 0.09 0.11
Stochastic Oscillator 69.19 36.11

Price Performance

Historical Comparison
SGHT
ELME

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.

Share on Social Networks: